Dyne Therapeutics
114 hedge funds and large institutions have $537M invested in Dyne Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 14 closing their positions.
Holders
114
Holders Change
-4
Holders Change %
-3.39%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
47
Reduced
32
Closed
14
Calls
$3.05M
Puts
$82K
Net Calls
+$2.96M
Net Calls Change
+$3.1M
Top Buyers
| 1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$9.27M |
| 2 |
B
2
Braidwell
Stamford,
Connecticut
|
$16.3M |
| 3 |
LGM
3
Logos Global Management
San Francisco,
California
|
$19.5M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$27.3M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$3.03M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Ameriprise
Minneapolis,
Minnesota
| – | – | -13,300 | Closed |
|
|
DA
127
Denali Advisors
San Diego,
California
| – | – | -2,700 | Closed |
|
128
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | – | -43 | Closed |
|
|
BFM
129
Boothbay Fund Management
New York
| – | – | – | – |
|
|
CFGS
130
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
IC
131
Ikarian Capital
Dallas,
Texas
| – | – | – | – |
|